ClinicalTrials.Veeva

Menu

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris (FREE)

Galderma logo

Galderma

Status and phase

Completed
Phase 3

Conditions

Acne

Treatments

Drug: Adapalene-BPO Gel standard+Cetaphil® Moisturizing Lotion
Drug: Adapalene BPO Gel standard daily overnight application
Drug: Adapalene-BPO 3-hour daily application before bedtime
Drug: Adapalene-BPO Gel every other day application

Study type

Interventional

Funder types

Industry

Identifiers

NCT00883233
RD.03.SPR.29085

Details and patient eligibility

About

The purpose of this study is to compare the tolerability of 3 treatment regimens containing Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel with that of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard daily overnight application for 12 weeks in the treatment of acne vulgaris. The efficacy of the four treatment regimens will also be evaluated.

Enrollment

123 patients

Sex

All

Ages

12 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female Subjects of any race, aged 12 to 35 years inclusive
  • Subjects with mild or moderate facial acne vulgaris
  • Subjects with skin phototype I to IV

Exclusion criteria

  • Subjects with more than 1 nodules or cysts on the face,
  • Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

123 participants in 4 patient groups

1
Experimental group
Description:
Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel 3-hour daily application before bedtime for first 4 weeks and then standard overnight daily application for the following 8 weeks
Treatment:
Drug: Adapalene-BPO 3-hour daily application before bedtime
2
Experimental group
Description:
Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel every other day application for the first 4 weeks and then standard overnight daily application for the following 8 weeks
Treatment:
Drug: Adapalene-BPO Gel every other day application
3
Experimental group
Description:
Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel standard daily overnight application with Cetaphil® Moisturizing Lotion application at wake-up time for the first 4 weeks and then standard daily overnight application for the following 8 weeks
Treatment:
Drug: Adapalene-BPO Gel standard+Cetaphil® Moisturizing Lotion
4
Active Comparator group
Description:
Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard daily overnight application for 12 week
Treatment:
Drug: Adapalene BPO Gel standard daily overnight application

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems